(Q34511043)

English

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Fernando Antoñanzas

3

object named as

Fernando Antoñanzas

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2

object named as

W John Edmunds

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Philippe Beutels

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

G Ardine De Wit

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

David Evans

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Rachel Feilden

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

A Mark Fendrick

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Gary M Ginsberg

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Henry A Glick

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Eric Mast

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Marc Péchevis

11

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Eddy K A Van Doorslaer

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Ben A van Hout

13

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Viral Hepatitis Prevention Board

14

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1-7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Accounting for future costs in medical cost-effectiveness analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11817988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of alternative hepatitis A immunisation strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/11817988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/11817988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/11817988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The transmission dynamics and control of hepatitis B virus in The Gambia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11817988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluations applied to HB vaccination: general observations

1 reference

https://pubmed.ncbi.nlm.nih.gov/11817988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/11817988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-benefit analysis of a nationwide infant immunization programme against hepatitis A in an area of intermediate endemicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/11817988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Universal or selective immunisation against hepatitis B virus in the United Kingdom? A review of recent cost-effectiveness studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/11817988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discounting and health benefits

1 reference

https://pubmed.ncbi.nlm.nih.gov/11817988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discounting costs and effects: a reconsideration

1 reference

https://pubmed.ncbi.nlm.nih.gov/11817988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and economic impact of a combination Haemophilus influenzae and Hepatitis B vaccine: estimating cost-effectiveness using decision analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11817988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discounting for health effects in cost-benefit and cost-effectiveness analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11817988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).

1 reference

https://pubmed.ncbi.nlm.nih.gov/11817988

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-200220010-00001

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34511043&oldid=2196726365"